Advertisement
Table 3 Uterine cancer characteristics, adjuvant therapy and disease status
| Characteristic | Uterine cancer (N = 53) |
|---|---|
| Pre-op Histology (n = 49) | |
| Endometrioid | 34 (69.4) |
| Serous | 6 (12.2) |
| Clear cell | 3 (6.1) |
| Carcinosarcoma | 3 (6.1) |
| Other/unspecified | 7 (14.3) |
| Post-op Histology | |
| Endometrioid | 40 (75.5) |
| Serous | 5 (9.4) |
| Clear cell | 1 (1.9) |
| Carcinosarcoma | 7 (13.2) |
| Grade | |
| 1 | 21 (39.6) |
| 2 | 15 (28.3) |
| 3 | 17 (32.1) |
| Stage | |
| IA | 28 (52.8) |
| IBa | 15 (28.3) |
| II | 1 (1.9) |
| IIIA | 2 (3.8) |
| IIIC1 | 3 (5.7) |
| IIIC2 | 2 (3.8) |
| IVB | 2 (3.8) |
| Lymph nodes | |
| Positive | 6 (11.32) |
| Negative | 29 (54.7) |
| Not collected | 18 (34.0) |
| Pelvic Washings | |
| Positive | 5 (9.4) |
| Negative | 41 (77.4) |
| Indeterminate/suspicious | 6 (11.3) |
| Not collected | 1 (1.9) |
| Adjuvant Therapyb | |
| Radiation | 13 (24.5) |
| Chemotherapy | 10 (18.9) |
| Hormonal | 4 (7.6) |
| Recurrence rate | 7 (13.2) |
| Median time to recurrence (days) | 395 [range 128–539] |
| Status of disease | |
| No evidence of disease | 43 (81.1) |
| Alive with diseasec | 3 (5.7) |
| Died of disease | 5 (9.4) |
| Died of intercurrent disease | 1 (1.9) |
| Died of unknown caused | 1 (1.9) |
